Estadísticas de Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response
Visitas totales
| views | |
|---|---|
| Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response | 6 |
Visitas totales por mes
| views | |
|---|---|
| octubre 2025 | 0 |
| noviembre 2025 | 0 |
| diciembre 2025 | 0 |
| enero 2026 | 0 |
| febrero 2026 | 0 |
| marzo 2026 | 6 |
| abril 2026 | 0 |
Descargas
| views | |
|---|---|
| munoz_atogepant_2026.pdf | 9 |
Visitas por país
| views | |
|---|---|
| España | 6 |
Visitas por ciudad
| views | |
|---|---|
| Bilbao | 6 |